Context Therapeutics Inc (CNTX) financials · $55.1M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Context Therapeutics Inc (CNTX) $55.1M cap.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Income | −$39.70M | −$29.92M | |
| Net Income | −$36.12M | −$26.73M | |
| EPS (Diluted) | −$0.38 | −$0.46 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $68.49M | $98.13M | |
| Current Assets | $68.35M | $97.90M | |
| Cash & Equivalents | $66.00M | $94.43M | |
| PP&E | $29.66K | $11.96K | |
| Total Liabilities | $8.02M | $2.86M | |
| Current Liabilities | $8.02M | $2.75M | |
| Shareholders' Equity | $60.47M | $95.27M | |
| Retained Earnings | −$130.90M | −$94.78M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$26.39M | −$14.56M | |
| CapEx | $33.95K | $7.32K | |
| Investing Cash Flow | −$2.03M | −$14.76M | |
| Financing Cash Flow | −$15.27K | $109.29M | |
| Net Change in Cash | −$28.43M | $79.98M | |
| Free Cash Flow | −$26.42M | −$14.56M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is CNTX P/E and revenue?
Context Therapeutics Inc (CNTX) $55.1M cap.
What is CNTX revenue?
CNTX income-statement cache has no revenue figure yet.
Is CNTX profitable?
Context Therapeutics Inc last cached net income is -$36.1M (FY2025).
What are CNTX total assets?
Context Therapeutics Inc last cached total assets are $68.5M (FY2025).
What is CNTX free cash flow?
Context Therapeutics Inc last cached free cash flow is -$26.4M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.